Chung Wu Investment Group, LLC Trevi Therapeutics, Inc. Transaction History
Chung Wu Investment Group, LLC
- $120 Billion
- Q3 2025
A detailed history of Chung Wu Investment Group, LLC transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Chung Wu Investment Group, LLC holds 1,600 shares of TRVI stock, worth $17,264. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,600
Previous 2,000
20.0%
Holding current value
$17,264
Previous $10.9 Million
33.82%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding TRVI
# of Institutions
173Shares Held
111MCall Options Held
1.07MPut Options Held
425K-
Nea Management Company, LLC Timonium, MD13.2MShares$143 Million6.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.3MShares$111 Million2.96% of portfolio
-
Rubric Capital Management LP New York, NY8.53MShares$92.1 Million1.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.32MShares$57.4 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA4.49MShares$48.4 Million5.2% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $629M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...